Although BRCA mutations often correlate with elevated PARP1 levels [199], not all BRCA-mutated cancers respond effectively to PARP inhibitors, and some non-BRCA-mutated cancers also exhibit high PARP1 expression [200]. The gene discussed is PARP1; the disease is cancer.